At the news
? BEARISHIMPACT 6/10 EFFECT filed Jul 22, 2026 at 00:15 ET
PDS Biotechnology Corp's $200M shelf registration (S-3) became effective on 2026-07-21, allowing the company to issue common stock, preferred stock, debt, warrants, units, and rights. Given the company's small market cap (~$43M), this represents substantial potential dilution and overhang on the stock.
- Shelf registration effective on 2026-07-21, File No. 333-297386.
- Authorizes up to $200 million in securities per prior S-3/A filing.
- Market cap approximately $43 million as of filing date.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access